Valuation: RaySearch Laboratories AB

Market Cap 585.96Cr 59Cr 52Cr 49Cr 45Cr 84Cr 5.66TCr 84Cr 226.95Cr 2.89TCr 221.83Cr 217.04Cr 9.3TCr P/E 2026 *
21.8x
P/E 2027 * 17.5x
Enterprise Value 601.46Cr 61Cr 53Cr 50Cr 46Cr 86Cr 5.81TCr 86Cr 232.95Cr 2.97TCr 227.7Cr 222.78Cr 9.54TCr EV / Sales 2026 *
4.31x
EV / Sales 2027 * 3.6x
Free-Float
80.09%
Yield 2026 *
2.29%
Yield 2027 * 2.74%
1 day+1.14%
1 week-2.87%
Current month-5.14%
1 month-4.75%
3 months-18.29%
6 months-6.81%
Current year-24.55%
1 week 167.8
Extreme 167.8
174.3
1 month 167
Extreme 167
186.9
Current year 161
Extreme 161
237
1 year 161
Extreme 161
262
3 years 79.99
Extreme 79.9948
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Chairman 81 18/11/2016
Director/Board Member 57 01/01/2000
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%-2.87% - - 59Cr
+2.12%+7.87%-3.30%+40.77% 4.54TCr
-1.63%-5.05%-46.65%+101.22% 1.18TCr
+2.59%-1.45%-7.46%+118.04% 554.06Cr
+1.05%-3.11%+48.73% - 427.55Cr
-5.25%-11.61% - - 194.45Cr
+1.91%+4.44%+9.57%-26.15% 153.54Cr
+0.08%-1.95%-35.57% - 100.78Cr
-0.61%-3.19%+9.98%+150.00% 96Cr
-1.14%-5.77%+30.96%+41.32% 86Cr
Average +0.03%-2.20%+0.78%+70.87% 815.33Cr
Weighted average by Cap. +1.19%+3.42%-7.27%+58.08%

Financials

2026 *2027 *
Net sales 139.65Cr 14Cr 12Cr 12Cr 11Cr 20Cr 1.35TCr 20Cr 54Cr 689.49Cr 53Cr 52Cr 2.22TCr 163.15Cr 16Cr 14Cr 14Cr 12Cr 23Cr 1.58TCr 23Cr 63Cr 805.52Cr 62Cr 60Cr 2.59TCr
Net income 27Cr 2.74Cr 2.41Cr 2.27Cr 2.07Cr 3.88Cr 262.87Cr 3.91Cr 11Cr 134.29Cr 10Cr 10Cr 431.6Cr 34Cr 3.4Cr 2.99Cr 2.82Cr 2.57Cr 4.81Cr 326.17Cr 4.85Cr 13Cr 166.63Cr 13Cr 13Cr 535.54Cr
Net Debt 16Cr 1.56Cr 1.37Cr 1.3Cr 1.18Cr 2.21Cr 149.8Cr 2.23Cr 6Cr 77Cr 5.87Cr 5.74Cr 245.95Cr 70L 7L 6L 6L 5L 10L 6.76Cr 10.05L 27.11L 3.46Cr 26.5L 25.93L 11Cr
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
25/26/25 SEK 173.40 +2.91% 8,509
24/26/24 SEK 168.50 -1.61% 9,765
23/26/23 SEK 171.25 +1.63% 7,384
22/26/22 SEK 168.50 -3.05% 1,919
21/26/21 SEK 173.80 -2.08% 1,261
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
174.30SEK
Average target price
297.50SEK
Spread / Average Target
+70.68%

Quarterly revenue - Rate of surprise